451 related articles for article (PubMed ID: 10545915)
1. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice.
Utomo AR; Nikitin AY; Lee WH
Nat Biotechnol; 1999 Nov; 17(11):1091-6. PubMed ID: 10545915
[TBL] [Abstract][Full Text] [Related]
2. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
[TBL] [Abstract][Full Text] [Related]
3. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
[TBL] [Abstract][Full Text] [Related]
4. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction.
Belteki G; Haigh J; Kabacs N; Haigh K; Sison K; Costantini F; Whitsett J; Quaggin SE; Nagy A
Nucleic Acids Res; 2005 Mar; 33(5):e51. PubMed ID: 15784609
[TBL] [Abstract][Full Text] [Related]
5. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
[TBL] [Abstract][Full Text] [Related]
6. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
Dacquin R; Starbuck M; Schinke T; Karsenty G
Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
[TBL] [Abstract][Full Text] [Related]
7. A novel technique for temporally regulated cell type-specific Cre expression and recombination in the pituitary gonadotroph.
Naik K; Pittman I; Wolfe A; Miller RS; Radovick S; Wondisford FE
J Mol Endocrinol; 2006 Aug; 37(1):63-9. PubMed ID: 16901924
[TBL] [Abstract][Full Text] [Related]
8. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
[TBL] [Abstract][Full Text] [Related]
9. Site- and time-specific gene targeting in the mouse.
Metzger D; Chambon P
Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
[TBL] [Abstract][Full Text] [Related]
10. Podocyte cell-specific expression of doxycycline inducible Cre recombinase in mice.
Juhila J; Roozendaal R; Lassila M; Verbeek SJ; Holthofer H
J Am Soc Nephrol; 2006 Mar; 17(3):648-54. PubMed ID: 16467448
[TBL] [Abstract][Full Text] [Related]
11. A system for inducible gene expression in retinal ganglion cells.
Kerrison JB; Duh EJ; Yu Y; Otteson DC; Zack DJ
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2932-9. PubMed ID: 16043868
[TBL] [Abstract][Full Text] [Related]
12. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
Licht AH; Raab S; Hofmann U; Breier G
Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
[TBL] [Abstract][Full Text] [Related]
13. Z/AP, a double reporter for cre-mediated recombination.
Lobe CG; Koop KE; Kreppner W; Lomeli H; Gertsenstein M; Nagy A
Dev Biol; 1999 Apr; 208(2):281-92. PubMed ID: 10191045
[TBL] [Abstract][Full Text] [Related]
14. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
Jäger R; Maurer J; Jacob A; Schorle H
Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
[TBL] [Abstract][Full Text] [Related]
15. F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expression.
Chiba H; Chambon P; Metzger D
Exp Cell Res; 2000 Nov; 260(2):334-9. PubMed ID: 11035928
[TBL] [Abstract][Full Text] [Related]
16. Cre-mediated recombination at the murine whey acidic protein (mWAP) locus.
Rucker EB; Piedrahita JA
Mol Reprod Dev; 1997 Nov; 48(3):324-31. PubMed ID: 9322243
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M
Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
[TBL] [Abstract][Full Text] [Related]
18. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice.
Yamauchi Y; Abe K; Mantani A; Hitoshi Y; Suzuki M; Osuzu F; Kuratani S; Yamamura K
Dev Biol; 1999 Aug; 212(1):191-203. PubMed ID: 10419695
[TBL] [Abstract][Full Text] [Related]
19. Targeting reverse tetracycline-dependent transactivator to murine mammary epithelial cells that express the progesterone receptor.
Mukherjee A; Soyal SM; Fernandez-Valdivia R; DeMayo FJ; Lydon JP
Genesis; 2007 Oct; 45(10):639-46. PubMed ID: 17941046
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
Jin C; McKeehan K; Wang F
Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
